Company news

11 May 2017

Alkor Bio Group has obtained the registration certificates for the tumor markers ELISA kits in Uzbekistan


At the beginning of May 3 ELISA kits produced by Alkor Bio has obtained The Ministry of Health of the Republic of Uzbekistan registration certificates. These kits are intended for diagnostics and monitoring of treatment of cancer: “OnkoEIA- CEA” for the quantitative determination of carcinoembryonic antigen (CEA) in human serum, “OncoEIA-CA 19-9” for the quantitative determination of cancer antigen CA 19-9 in human serum and “EIA-Ferritin” for the quantitative determination of ferritin in human serum.

Since 2002 Alkor Bio Group has provided to Uzbekistan 15 reagent kits for hormonal diagnostics, allergy diagnostics, prenatal screening, including the risk of Down’s syndrome. All these kits have registration certificates in Uzbekistan.

At the present time Alkor Bio’s catalogue comprises more than 80 names of products for ELISA and PCR diagnostics. Besides Uzbekistan Alkor Bio products are exported to Belorussia, Georgia, Kazakhstan, Kyrgyzstan, Ukraine, Germany, Italy, Iran, Brazil and many other countries around the world. In the future Alkor Bio Group will expand the geography of the products supply.